• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

From the Experts

[WEBINAR] Targeting ALS: Inside the Mission | Recording and Q&A

Stephanie Ishoo · May 29, 2025 ·

Women in Science at Target ALS: Breaking Barriers, Driving Discovery

Melissa Rentfrow · Mar 26, 2025 ·

Perseverance and Prevailing: A Seven-Year Journey in Neuroscientific Innovation

Melissa Rentfrow · Mar 19, 2025 ·

Target ALS Postmortem Tissue Core Facilitates Groundbreaking Research on SOD1 Protein Aggregation.

From Paris, With Love for Science: Dr. Latouche’s Groundbreaking ALS Research

Melissa Rentfrow · Mar 19, 2025 ·

Mind the Gap: Sabine Liebscher is Connecting the Dots of ALS

Melissa Rentfrow · Mar 6, 2025 ·

Researchers Report on the Opposing Roles of p38α Phosphorylation and Protein Arginine Methyltransferase 1 (PRMT1) Methylation in TDP-43 Proteinopathy

Ellen Guss · Feb 11, 2025 ·

Addressing Inequities in ALS Healthcare: The Critical Need for Diversity in Research

Melissa Rentfrow · Nov 13, 2024 ·

The Ultimate Guide to Cognitive Impairment, Dementia, and ALS

Melissa Rentfrow · Feb 1, 2023 ·

Therapeutic Target HDAC6 and ALS

Melissa Rentfrow · Jan 6, 2023 ·

HDAC6
  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

Name(Required)
Interests(Required)
Mark the options that best describe your interest in ALS